Related Experiment Video
Updated: Jun 7, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
[What is proven in the treatment of complement-mediated kidney diseases?]
Jessica Kaufeld1, Svjetlana Lovric2
1Klinik für Nieren- und Hochdruckerkrankungen, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. kaufeld.jessica@mh-hannover.de.
Insights
Dysregulated complement system activation causes kidney diseases like atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy. Novel therapies targeting the complement system offer new treatment options for these complex conditions.
Area of Science:
- The complement system, a vital part of innate immunity, involves proteins essential for pathogen defense and homeostasis.
- Dysregulation of this system can trigger exaggerated responses, leading to kidney damage and diseases.
Context:
- Complement-mediated kidney diseases, including atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (a form of MPGN), arise from complement system dysregulation.
- Immune complex deposition in glomeruli can activate complement, driving kidney disease progression.
Purpose:
- To provide an overview of complement regulation mechanisms.
- To explain the pathophysiology of complement-mediated kidney diseases.
- To highlight recent advancements in diagnosis and therapy.
Summary:
- Diagnosing these kidney diseases involves investigating triggers, genetic factors, and specific complement levels.
- New therapeutic strategies focus on drugs that specifically target complement system activation, differing from traditional immunosuppressants.
- An interdisciplinary approach is crucial for understanding and managing these complex conditions.
Impact:
- Advances in understanding complement regulation and pathophysiology are improving diagnostic accuracy.
- Targeted therapies offer promising new treatment avenues for patients with complement-mediated kidney diseases.
- Emphasizes the need for collaborative research and clinical management for better patient outcomes.
Abstract:
Complement-mediated kidney diseases encompass a complex group of diseases that are primarily caused by dysregulation of the complement system. The complement system is a crucial component of the innate immune system consisting of soluble and membrane-bound proteins. The complement system is essential for the defence against pathogens and homeostasis but its uncontrolled activation can lead to an exaggerated cellular response to immunogenic, inflammatory and metabolic stimuli. For example, glomerular deposition of immune complexes can activate the complement system and contribute to the progression of kidney diseases. The most well-known complement-mediated kidney diseases are atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy, which falls under the group of membranoproliferative glomerulonephritis (MPGN). Diagnosing these diseases requires detailed investigations with respect to triggering factors, including genetic analyses and the measurement of specific complement factors. New therapeutic approaches with drugs targeting complement system activation are now offering promising treatment options. These medications fundamentally differ from other immunosuppressive drugs and specifically target the pathological processes within the complement system. This article provides an overview of the mechanisms of complement regulation, the pathophysiological foundations of complement-mediated kidney diseases and the latest diagnostic and therapeutic advances. The goal is to provide a deeper understanding of these complex conditions and to emphasize the importance of an interdisciplinary approach in treatment and research.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Drug Elimination by Renal Route: Tubular Secretion
Nephrons
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

